Baldasseroni Samuele, Opasich Cristina, Gorini Marco, Lucci Donata, Marchionni Niccolò, Marini Maurizio, Campana Carlo, Perini Giampaolo, Deorsola Antonella, Masotti Giulio, Tavazzi Luigi, Maggioni Aldo P
Italian Association of Hospital Cardiologists Research Center, Florence, Italy.
Am Heart J. 2002 Mar;143(3):398-405. doi: 10.1067/mhj.2002.121264.
A deleterious effect of complete left bundle-branch block (LBBB) on left ventricular function has been established. Nevertheless, the independent effect of a widened QRS on mortality rate in congestive heart failure (CHF) is still controversial. Therefore, we carried out this analysis to determine whether LBBB is an independent predictor of mortality in CHF.
We analyzed the large Italian Network on CHF Registry of unselected outpatients with CHF of different causes. The registry was established by the Italian Association of Hospital Cardiologists in 1995. Complete 1-year follow-up data were available for 5517 patients. The main underlying cardiac diagnosis was ischemic heart disease in 2512 patients (45.6%), dilated cardiomyopathy in 1988 patients (36.0%), and hypertensive heart disease in 714 patients (12.9%). Other causes were recorded in the remaining 303 cases (5.5%). LBBB was present in 1391 patients (25.2%) and was associated with an increased 1-year mortality rate from any cause (hazard ratio, 1.70; 95% confidence interval, 1.41 to 2.05) and sudden death (hazard ratio, 1.58; 95% confidence interval, 1.21 to 2.06). Multivariate analysis showed that such an increased risk was still significant after adjusting for age, underlying cardiac disease, indicators of CHF severity, and prescription of angiotensin-converting enzyme inhibitors and beta-blockers.
LBBB is an unfavorable prognostic marker in patients with CHF. The negative effect is independent of age, CHF severity, and drug prescriptions. These data may support the rationale of randomized trials to verify the effects on mortality rate of ventricular resynchronization with multisite cardiac pacing in patients with CHF and LBBB.
完全性左束支传导阻滞(LBBB)对左心室功能的有害影响已得到证实。然而,QRS波增宽对充血性心力衰竭(CHF)死亡率的独立影响仍存在争议。因此,我们进行了这项分析,以确定LBBB是否为CHF死亡率的独立预测因素。
我们分析了意大利心力衰竭大型网络中不同病因的未选择门诊CHF患者的登记资料。该登记资料由意大利医院心脏病学家协会于1995年建立。5517例患者有完整的1年随访数据。主要潜在心脏诊断为缺血性心脏病2512例(45.6%),扩张型心肌病1988例(36.0%),高血压性心脏病714例(12.9%)。其余303例(5.5%)记录为其他病因。1391例患者(25.2%)存在LBBB,且与任何原因导致的1年死亡率增加相关(风险比,1.70;95%置信区间,1.41至2.05)以及心源性猝死(风险比,1.58;95%置信区间,1.21至2.06)。多变量分析显示,在调整年龄、潜在心脏病、CHF严重程度指标以及血管紧张素转换酶抑制剂和β受体阻滞剂的处方后,这种增加的风险仍然显著。
LBBB是CHF患者不良的预后标志物。其负面影响独立于年龄、CHF严重程度和药物处方。这些数据可能支持进行随机试验的理论依据,以验证多部位心脏起搏心室再同步化对CHF合并LBBB患者死亡率的影响。